Wuiame SRL
1.3 FTEWuiame reported total assets of €1.97m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026), with 1.3 full-time equivalent.
The score of Wuiame shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -80 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wuiame's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Wuiame's financial analysis
- Solvency4.7%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wuiame
Wuiame's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0700.471.741
- VAT number
- BE0700471741
- Peppol
- Registered · 0208:0700471741 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jul 2018
- Registered office
- 1340 Ottignies-Louvain-la-Neuve
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Wuiame (SRL) has been based in Ottignies-Louvain-la-Neuve since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 186,011 € and equity of 92,631 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 4.7%, below the median of its sector (40.1%).
Companies similar to Wuiame
Companies in the same business, of comparable size and area, outside its group.
- Krito Pharma Retail sale of pharmaceutical products Tervuren · balance sheet €2.01m
- Hustings JO Management Retail sale of pharmaceutical products Wellen · balance sheet €2.13m
- Holding La Pharma Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.15m
- Libra Pharma Retail sale of pharmaceutical products Boechout · balance sheet €3.57m
- Vanheusden Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet €3.62m
- Pharmacie Herbint Retail sale of pharmaceutical products Evere · balance sheet €1.83m
- Pharmarive Retail sale of pharmaceutical products Etterbeek · balance sheet €1.80m
- Apotes Retail sale of pharmaceutical products Herk-de-Stad · balance sheet €4.46m
Frequently asked questions about Wuiame
What is the revenue of Wuiame?
Wuiame files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wuiame?
In Belgium, the VAT number is the company number prefixed with BE: BE0700471741 for Wuiame, if the company is VAT-registered. Its company number (CBE) is 0700.471.741.
Where is the registered office of Wuiame?
According to the CBE register, the registered office of Wuiame is in 1340 Ottignies-Louvain-la-Neuve.
What is the equity of Wuiame?
At the close of the 2025 financial year, the equity of Wuiame amounts to 92,631 €, a solvency of 4.7% of total assets.
How many people work at Wuiame?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Wuiame?
The register lists 5 active mandates at Wuiame. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wuiame
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →